Anaplastic Oligodendroglioma

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 12 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

Anaplastic oligodendroglioma is a grade 3 (faster-growing) brain tumor that starts from cells called oligodendrocytes, which help make the insulation (myelin) around brain nerve fibers. Today, doctors define this tumor by its molecular “fingerprint”: the tumor must carry an IDH gene mutation (IDH1 or IDH2)...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

Anaplastic oligodendroglioma is a grade 3 (faster-growing) brain tumor that starts from cells called oligodendrocytes, which help make the insulation (myelin) around brain nerve fibers. Today, doctors define this tumor by its molecular “fingerprint”: the tumor must carry an IDH gene mutation (IDH1 or IDH2) and a combined loss of two chromosome arms called 1p/19q codeletion. When a tumor has both of these changes and...

Key Takeaways

  • This article explains Other names in simple medical language.
  • This article explains Types in simple medical language.
  • This article explains Causes & risk factors in simple medical language.
  • This article explains Common symptoms in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Severe symptoms, breathing difficulty, fainting, confusion, or rapidly worsening illness.
  • New weakness, severe pain, high fever, or symptoms after a serious injury.
  • Any symptom that feels urgent, unusual, or unsafe for the patient.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.

Anaplastic oligodendroglioma is a grade 3 (faster-growing) brain tumor that starts from cells called oligodendrocytes, which help make the insulation (myelin) around brain nerve fibers. Today, doctors define this tumor by its molecular “fingerprint”: the tumor must carry an IDH gene mutation (IDH1 or IDH2) and a combined loss of two chromosome arms called 1p/19q codeletion. When a tumor has both of these changes and looks like an oligodendroglioma under the microscope, and the tissue shows high-grade features (e.g., brisk mitoses and/or microvascular proliferation), it is called oligodendroglioma, IDH-mutant and 1p/19q-codeleted, CNS WHO grade 3—the current name for what used to be called “anaplastic oligodendroglioma.” College of American Pathologists+3PMC+3PMC+3

Compared with other adult-type diffuse gliomas, oligodendrogliomas are uncommon and typically affect adults in their 30s–50s, often in the frontal lobe. They frequently present with seizures and other focal brain symptoms. NCBI+2PMC+2

Other names

  • Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, CNS WHO grade 3 (current preferred term). PMC

  • Anaplastic oligodendroglioma (older term; still common in clinical notes, but “anaplastic” is no longer the official label). College of American Pathologists+1

  • High-grade oligodendroglioma (informal description meaning grade 3). NCBI

Types

Oligodendrogliomas are grouped by WHO 2021 as adult-type diffuse gliomas and split by grade and molecular features:

  1. CNS WHO grade 2 – slower-growing oligodendroglioma (IDH-mutant, 1p/19q-codeleted).

  2. CNS WHO grade 3 – faster-growing oligodendroglioma (IDH-mutant, 1p/19q-codeleted) with higher mitotic activity and often microvascular proliferation; this corresponds to the historical term anaplastic oligodendroglioma. PMC+2PMC+2

(Notes: “Anaplastic” is now avoided in formal naming, but many clinicians still use it to mean grade 3. Some grade-3 tumors may also show microvascular proliferation and even necrosis; these findings correlate with more aggressive behavior.) NCBI+1

Causes & risk factors

Strictly speaking, the exact “cause” is unknown for most people. Instead, doctors talk about drivers and risk associations—changes inside tumor cells and a few conditions that raise the chance of a glioma. Here are 20 important ones, each in plain language:

  1. IDH1 or IDH2 mutation (driver event). An early DNA change that rewires cell metabolism and helps start a glioma; it’s required for this diagnosis. PMC

  2. 1p/19q codeletion (defining event). Loss of genetic material on the short arm of chromosome 1 and long arm of 19; together with IDH mutation, it defines oligodendroglioma. PMC

  3. TERT promoter mutation. Very common (>80–90%) in IDH-mutant, 1p/19q-codeleted tumors; supports continuous cell division by activating telomerase. PMC+1

  4. CIC gene mutation. A frequent alteration in codeleted tumors that influences cell growth programs. PMC+1

  5. FUBP1 gene mutation. Another recurrent tumor-suppressor alteration associated with oligodendroglioma biology. PMC+1

  6. NOTCH pathway changes (e.g., NOTCH1). Reported in subsets of oligodendroglioma and may affect cell signaling. Wiley Online Library

  7. PI3K/AKT/mTOR pathway alterations (e.g., PIK3CA/PTEN). Less common drivers that can promote growth signaling. (Summarized across genomic series.) Wiley Online Library

  8. CDKN2A/2B homozygous deletion. A poor-prognosis event found in some grade-3 tumors; it disables key cell-cycle brakes. Department of Pathology

  9. Retained ATRX (and low p53) pattern. Not a risk itself but a characteristic of oligodendroglioma compared with astrocytoma (which often loses ATRX); helps pathologists confirm the tumor type. SpringerLink

  10. Prior cranial irradiation. Rarely, past brain radiation can increase later glioma risk. (Association reported for diffuse gliomas.) Cleveland Clinic

  11. Hereditary cancer syndromes (Li-Fraumeni). TP53-related syndrome increases overall glioma risk (not specific to oligodendroglioma). (General neuro-oncology consensus.) PMC

  12. Mismatch repair syndromes (Lynch/Turcot). Raise glioma risk in some families; not specific but recognized. (General guideline discussions.) Nature

  13. Somatic IDH mosaicism disorders (Ollier/Maffucci). Rare disorders with early IDH changes; linked to higher glioma risk. SpringerLink

  14. Age (adult peak 35–50+). Oligodendrogliomas occur mostly in adults; grade-3 skew slightly older than grade-2. PMC+1

  15. Male sex (slight excess). Many series report a modest male predominance. PMC+1

  16. Frontal/temporal lobe location predisposition. Not a “cause,” but these lobes are the common sites where tumors arise. PMC

  17. Telomere biology shifts (TERT-p). The telomerase changes that maintain chromosome ends facilitate long-term tumor growth. PMC

  18. Epigenetic profile (DNA methylation class). Oligodendrogliomas form a distinct methylation class; this profile reflects underlying biology that favors this tumor type. SpringerLink

  19. CIC/FUBP1 haploinsufficiency from 1p/19q loss. The whole-arm codeletion may “dose-reduce” these genes and contribute to tumor development. BioMed Central

  20. General unknown environmental factors. For most patients, no clear outside trigger is found; research continues. (Consensus across reviews.) PMC

Common symptoms

  1. Seizures. Very common first sign, especially with frontal lobe tumors; abnormal electrical activity causes convulsions or brief spells. PMC

  2. pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">Headache. Can come from pressure effects or swelling around the tumor. Cleveland Clinic

  3. Nausea/vomiting. Often accompanies raised intracranial pressure (ICP). Cleveland Clinic

  4. Personality or behavior change. Frontal lobe involvement may cause apathy, disinhibition, or irritability. Columbia Neurosurgery in New York City

  5. Speech or language problems. Tumors in dominant frontal/temporal regions can produce word-finding trouble or aphasia. Columbia Neurosurgery in New York City

  6. Weakness (one side). Involvement of motor pathways leads to loss of strength, clumsiness, or slower movements. Stroke Manual

  7. Numbness or tingling. Sensory cortex or white-matter pathway involvement can cause altered sensation. Stroke Manual

  8. Vision loss or field cuts. Occipital or optic-pathway involvement can reduce visual fields; papilledema can blur vision if ICP is high. Merck Manuals

  9. Double vision. Elevated ICP can cause sixth-nerve palsy and eye movement problems. EyeWiki

  10. Balance or coordination problems. Cerebellar or fronto-parietal pathway involvement affects gait and fine movements. Stroke Manual

  11. Cognitive slowing and memory issues. Diffuse network disruption leads to slower thinking or forgetfulness. Neurology at Washington University

  12. Fatigue and sleep disturbance. Seizures, medications, and tumor burden commonly cause tiredness. (Clinical experience summarized in reviews.) Cancer.gov

  13. Mood or anxiety symptoms. Brain network changes and uncertainty about illness can drive anxiety or depression. (Patient-facing resources concur.) National Brain Tumor Society

  14. Smell/taste changes. If the tumor involves orbitofrontal or temporal networks. Columbia Neurosurgery in New York City

  15. Papilledema (optic disc swelling). A sign of raised ICP seen on eye exam; may cause transient vision dimming. Cleveland Clinic+1

Diagnostic tests

A) Physical examination

  1. Complete neurologic exam. Checks mental status, cranial nerves, strength, reflexes, sensation, coordination, and gait to localize the problem. Abnormalities point clinicians to where the tumor might be. NCBI

  2. General physical and vitals. Identifies systemic clues (e.g., blood pressure elevations with pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">headache from ICP) and fitness for procedures. (Standard practice sources.) Hopkins Medicine

  3. Eye (fundus) exam. Looks for papilledema, which supports raised intracranial pressure from a mass; urgent if present. Cleveland Clinic+1

  4. Bedside visual field testing. Confrontation fields can reveal missing portions of vision from occipital or optic-radiation involvement. (Neuro exam references.) NCBI

B) Manual bedside tests

  1. Pronator drift. A simple arm-holding test that picks up subtle weakness from motor-pathway lesions. meded.ucsd.edu

  2. Romberg test. Checks balance using vision, proprioception, and cerebellar input—instability may reflect sensory or cerebellar pathway issues. meded.ucsd.edu

  3. Finger-to-nose / heel-to-shin. Coordination maneuvers that detect cerebellar or connection problems caused by tumor infiltration. Neurology at Washington University

  4. Brief cognitive screening (e.g., orientation, memory, language). Quick bedside checks help detect cortical dysfunction from frontal/temporal lesions. NCBI

C) Laboratory & pathological tests

  1. Surgical biopsy / resection for histology (H&E). Confirms a diffuse glioma with oligodendroglial features (uniform cells, “chicken-wire” vasculature) and grade-3 activity such as brisk mitoses; microvascular proliferation and necrosis can be seen in higher-grade behavior. NCBI+1

  2. IDH1 R132H immunohistochemistry (IHC). A fast screen for the common IDH1 mutation; highly reliable, with sequencing used when negative/equivocal. BioMed Central+1

  3. 1p/19q codeletion testing (FISH/NGS/LOH). Essential to prove oligodendroglioma; required along with IDH mutation to make the diagnosis. PMC

  4. ATRX and p53 IHC. Oligodendrogliomas typically retain ATRX and have lower p53 expression than astrocytomas; this pattern supports the diagnosis. Lippincott Journals

  5. TERT promoter mutation testing. Very common in codeleted oligodendroglioma; helps round out the molecular profile and may carry prognostic value. PMC

  6. MGMT promoter methylation (pyrosequencing/MSP). Often methylated; relevant to prognosis and therapy sensitivity in diffuse gliomas. PMC

  7. Ki-67 (MIB-1) proliferative index. Estimates how quickly tumor cells are dividing; tends to be higher in grade-3 disease. (Pathology reviews.) Department of Pathology

(Advanced profiling often includes DNA methylation class—a genome-wide signature that can resolve difficult cases and, in some settings, can even “establish” the oligodendroglioma class when concordant.) SpringerLink

D) Electro-diagnostic tests

  1. EEG (electroencephalogram). Records brain waves to evaluate seizures common in oligodendroglioma; useful to classify spells and guide anti-seizure therapy, though not tumor-specific. (Standard neuro-oncology practice.) NCBI

  2. Evoked potentials (VEP, SSEP) when relevant. Measure pathway conduction (vision or somatosensory). They’re most useful for surgical planning/monitoring to protect function near eloquent cortex. NCBI+1

  3. Intraoperative neurophysiologic monitoring (SSEPs/MEPs/VEPs). During tumor removal, live monitoring helps surgeons avoid injury to motor, sensory, or visual pathways. PMC+1

E) Imaging tests

  1. MRI brain with and without contrast (gold standard imaging). Shows tumor location, size, and spread along white matter; grade-3 lesions may enhance and often sit in the frontal lobe. PMC

  2. CT head. Useful quickly and for calcifications, which are common in oligodendroglioma. Radiopaedia

  3. MR perfusion (rCBV). Measures tumor blood volume; higher values suggest higher grade and more vascular tumor tissue. J Pathol Transl Med

  4. MR spectroscopy. Looks at brain chemicals; oligodendrogliomas often show high choline (cell turnover) and low N-acetylaspartate (NAA) (neuronal marker). (Imaging reviews.) PMC

  5. Diffusion-weighted MRI. Helps assess cellularity and tumor heterogeneity (lower ADC can suggest higher cellular density). PMC

  6. Amino-acid PET (e.g., FET-PET) when available. Can help distinguish treatment change vs. progression and refine target areas; increasingly used with MRI. SpringerLink

 

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 16, 2025.

 

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Anaplastic Oligodendroglioma

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Combined Immunodeficiency with Childhood-Onset Kaposi Sarcoma

    Combined immunodeficiency with childhood-onset Kaposi sarcoma is a very rare genetic immune system disease. In this disease, a gene called TNFRSF4 does not work properly. This...

    February 14, 2026 • Rx Cancer (A - Z)
  2. Collecting Duct Renal Cell Carcinoma

    Collecting duct renal? cell carcinoma is a rare and very aggressive type of kidney cancer. It starts in the small tubes at the very end of...

    February 10, 2026 • Rx Cancer (A - Z)
  3. Collecting Duct Carcinoma of the Kidney

    Collecting duct carcinoma of the kidney is a very rare and very aggressive type of kidney cancer. It starts in the last part of the kidney...

    February 10, 2026 • Rx Cancer (A - Z)
  4. Kidney Collecting Duct Carcinoma

    Kidney collecting duct carcinoma is a rare, very aggressive type of kidney cancer. It starts in the tiny tubes at the end of the kidney’s filtering...

    February 10, 2026 • Rx Cancer (A - Z)
  5. Carcinoma of the Collecting Duct of the Renal Tubule

    Carcinoma of the collecting duct of the renal? tubule is a rare and very aggressive cancer that starts in the tiny tubes in the middle part...

    February 10, 2026 • Rx Cancer (A - Z)
  6. Bellini Carcinoma

    Bellini carcinoma is a very rare and very aggressive type of kidney cancer. It starts in the last part of the tiny tubes in the kidney...

    February 10, 2026 • Rx Cancer (A - Z)
  7. Collecting Duct Carcinoma

    Collecting duct carcinoma is a rare and very aggressive type of kidney cancer. It starts in the tiny tubes at the end of the kidney’s filtering...

    February 10, 2026 • Rx Cancer (A - Z)
  8. Paediatric Kidney Clear Cell Sarcoma

    Paediatric kidney clear cell sarcoma (often shortened to clear cell sarcoma of the kidney, CCSK) is a rare type of kidney cancer that happens mainly in...

    January 29, 2026 • Rx Cancer (A - Z)
  9. Clear Cell Sarcoma of the Kidney (CCSK)

    Clear cell sarcoma of the kidney (CCSK) is a rare type of kidney cancer that happens mostly in young children, usually under 5 years of age....

    January 29, 2026 • Rx Cancer (A - Z)
  10. Cystic-Multilocular Variant; Grawitz Tumor

    Cystic-multilocular variant; Grawitz tumor is a type of kidney cancer that forms many fluid-filled spaces (cysts) separated by thin walls inside the kidney. It belongs to...

    January 28, 2026 • Rx Cancer (A - Z)